SCHEMBL30267455

SCHEMBL30267455

CC(=O)N[C@H]1[C@@H](O[C@H]2[C@@H](O)[C@@H](CO)O[C@@H](O[C@H]3[C@H](O)[C@@H](NC(C)=O)C(O)O[C@@H]3CO)[C@@H]2O[C@@H]2O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]2O)O[C@H](CO)[C@H](O)[C@@H]1O

nearest known ligand 0.56

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ LGALS3 P17931 6/20 0.56
▸ LGALS8 O00214 1/20 0.56
▸ LGALS4 P56470 1/20 0.56
▸ CD69 Q07108 1/20 0.49
▸ CHIA Q9BZP6 1/20 0.49
▸ MAPK1 P28482 2/20 0.47
▸ AMY2A P04746 3/20 0.47
▸ ALDH1A1 P00352 1/20 0.46
▸ THRB P10828 1/20 0.46
▸ LGALS9 O00182 1/20 0.45
▸ LGALS1 P09382 1/20 0.44
▸ LGALS7; LGALS7B P47929 1/20 0.44
▸ AMY1A P0DUB6 1/20 0.44
▸ GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29532739 1.00 LGALS3 (0.56) LGALS3LGALS8LGALS4CD69CHIA
SCHEMBL30565919 1.00 LGALS3 (0.56) LGALS3LGALS8LGALS4CD69CHIA
SCHEMBL29532634 0.97 LGALS3 (0.56) LGALS3LGALS8LGALS4CD69CHIA
SCHEMBL29912771 0.95 LGALS3 (0.55) LGALS3LGALS8LGALS4CD69CHIA
SCHEMBL29632864 0.95 LGALS3 (0.55) LGALS3LGALS8LGALS4CD69CHIA
SCHEMBL30564573 0.95 MAPK1 (0.53) LGALS3LGALS8LGALS4CD69CHIA
SCHEMBL29407990 0.95 LGALS3 (0.56) LGALS3LGALS8LGALS4CD69CHIA
SCHEMBL31700321 0.94 LGALS3 (0.55) LGALS3LGALS8LGALS4CD69CHIA
SCHEMBL31700821 0.94 LGALS3 (0.55) LGALS3LGALS8LGALS4CD69CHIA
SCHEMBL31701501 0.94 LGALS3 (0.55) LGALS3LGALS8LGALS4CD69CHIA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230279403-A1 PRODUCTION OF ALPHA-1,3 GLYCOSYLATED FORM OF FUC-A1,2-GAL-R INBIOSE N.V. (BE) 2023-09-07 — — US disclosed
Send feedback